A Comprehensive Systematic Review of Relationship Between Hba1c Levels and The Risk of Diabetic Retinopathy
Keywords:
Diabetic retinopathy, HbA1c, glycemic control, systematic review, diabetes complications, risk factorsAbstract
Introduction: Diabetic retinopathy (DR) remains a leading cause of preventable blindness worldwide, with glycemic control identified as a critical modifiable risk factor. Despite extensive research, evidence gaps persist regarding optimal HbA1c thresholds, the role of glycemic variability, and the consistency of the HbA1c-DR relationship across diverse populations. This systematic review aims to comprehensively synthesize global evidence on the association between HbA1c levels and DR risk, severity, and progression.
Methods: A systematic review was conducted following PRISMA guidelines. We screened studies based on predefined criteria including diabetes population, HbA1c measurement, DR outcome assessment, and study design. Data extraction encompassed study characteristics, HbA1c measurement methodology, DR assessment methods, association measures, moderating factors, and statistical approaches. The review synthesized evidence from 200 included studies encompassing diverse geographic regions and both Type 1 and Type 2 diabetes populations.
Results: A strong, consistent positive association between elevated HbA1c and DR risk was demonstrated across all study designs and populations. Quantitative synthesis revealed that a 10% relative reduction in HbA1c decreases retinopathy progression risk by 43-45%, and each 1% absolute HbA1c reduction confers approximately 35% risk reduction. Mean HbA1c levels were consistently higher in DR patients versus those without (range: 8.09-9.50% vs. 7.21-8.49%). A dose-response relationship was evident, with progressive HbA1c elevation correlating with increasing DR severity. Threshold effects were identified at 7.0%, with substantially accelerated risk above 8.6%. HbA1c variability emerged as an independent predictor. Diabetes duration, hypertension, and dyslipidemia significantly moderated the relationship.
Conclusion: This review establishes HbA1c as a dominant, modifiable, dose-dependent risk factor for diabetic retinopathy across all diabetes types and populations. No absolute safe threshold exists; risk reduction follows HbA1c improvement continuously. We recommend intensive, early glycemic control targeting individualized HbA1c goals, integrated multifactorial risk management, and incorporation of HbA1c variability into risk stratification. Future research should focus on establishing population-specific thresholds and investigating HbA1c variability intervention strategies.
References
A. A. Lestari, Ekarini Katharina Yunarti Nabu, A. A. M. P. Triningrat, I. Wande, I. A. P. Wirawati, N. N. Mahartini, T. H. Cong, and I. Prabawa. “The Correlation Between HbA1c and MCP-1 Levels in Diabetic Retinopathy Patients.” INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY, 2025.
A. Jatoi. “Assessment of Risk Factors for the Development of Diabetic Retinopathy in T2D.” Modern Medicine, 2024.
A. Romadhon, Nanang Miftah Fajari, M. Faisal, Fauzia Noor Liani, and Azma Rosida. “HUBUNGAN KADAR HBA1C TERHADAP MANIFESTASI RETINOPATI PADA PASIEN DIABETES MELITUS.” Homeostasis, 2025.
A. Sattar, and Hussain Ali Tufaili. “Risk Factors for Diabetic Retinopathy in Type 2 Diabetes Mellitus.” Journal of Health, Medicine and Nursing, 2020.
Abdul Jabbar, Muhammad Yaqoob Khan, Momin Khan, Zia Ullah, Salman Khan, Fawad Ali, and Fawad Khalid. “Correlation Between Diabetic Retinopathy Severity and HbA1c Levels.” Pakistan Journal of Medical & Health Sciences, 2023.
Adriana Ivanescu, Simona Popescu, Radu Ivanescu, Monica Potra, and R. Timar. “Predictors of Diabetic Retinopathy in Type 2 Diabetes: A Cross-Sectional Study.” Biomedicines, 2024.
Ahmed Salah Abdel Rehim, mohamed altbbal, and Mahmoud Mohamed Barghout. “Assessment of Retinal Nerve Fiber Layer Thickness Using Optical Coherence Tomograghy (OCT) in Patients with Diabetic Retinopathy in Relation to HbA1c.” Al-Azhar International Medical Journal, 2022.
Aisyah Primaputri, Sri Irmandha, M. Karim, Prema Hapsari, Zulfiyah Surdam, Rismayanti, Paulus, and Ade Rahmy Sujuthi. “Hubungan Jenis Retinopati Diabetik Dengan Lama Menderita Diabetes Melitus Dan Kadar HbA1C.” FAKUMI MEDICAL JOURNAL Jurnal Mahasiswa Kedokteran, 2022.
Ali H Alarbash, Saad N Almutairi, Hamad R Alazmi, Abdulrahman N Almutairi, and Abdullah N Almutairi. “The Contributions of Glycated Hemoglobin (HbA1c), Triglycerides, and Hypertension to Diabetic Retinopathy: Insights From a Meta-Analysis.” Cureus, 2025.
Amr Muhammad Badr Salah El-Deen, H. M. Sammor, and Mohammed Al Taher Abd El-Wahab. “OCT ASSESSMENT OF MACULAR THICKNESS IN NON-PROLIFERATIVE DIABETIC RETINOPATHY IN RELATION TO GLYCOSYLATED HEMOGLOBIN,” 2021.
“An Observational Study on the Association Between Diabetic Retinopathy and Serum Lipid Levels in a Tertiary Centre in Thiruvananthapuram.” Journal of Evidence Based Medicine and Healthcare, 2021.
Angelyn Bethel, R. Diaz, N. Castellana, Indranil Bhattacharya, H. Gerstein, and M. Lakshmanan. “HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-Analysis and Meta-Regression.” Diabetes Care, 2020.
Anup Mondal, Surya Sekhar Das, and Anik Ghosh. “COMPARISON OF SERUM LEVELS OF GLYCOSYLATED HAEMOGLOBIN AND FERRITIN IN TYPE 2 DIABETIC PATIENTS WITH AND WITHOUT DIABETIC RETINOPATHY.” International Journal of Scientific Research, 2025.
Anusha N Sangapur, Ravi N Sangapur, and Varsha Huralikoppi. “A Study of Retinal Changes in Diabetes Mellitus in Association with Glycosylated Haemoglobin, Haemoglobin and Duration of Diabetes Mellitus in Tertiary Care Teaching Hospital.” International Journal of Medical Ophthalmology, 2021.
April Y. Maa, and B. R. Sullivan. “Relationship of Hemoglobin A1C with the Presence and Severity of Retinopathy Upon Initial Screening of Type II Diabetes Mellitus.” American Journal of Ophthalmology-Glaucoma, 2007.
Archana Thool, Nikunj Kishore Dhande, and S. Daigavane. “Study of Correlation Between Renal Function Test and Severity of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.” Journal of Evolution of Medical and Dental Sciences, 2021.
Atif Mansoor Ahmed, Irum Abbas, and Sohail Ahmed Siddiqui. “Hba1c Levels an Indicator of Glycemic Control in Diabetics With and Without Retinopathy.” Proceedings, 2023.
B. Longo-Mbenza, M. Muaka, G. Mbenza, S. Mbungu-Fuele, V. Nzuzi, and J. Mbadi-A-Sungu. “Risk Factors of Poor Control of HBA1c and Diabetic Retinopathy: Paradox with Insulin Therapy and High Values of HDL in African Diabetic Patients.” International Journal of Diabetes and Metabolism, 2008.
B. Ozmen, and Sibel Boyvada. “The Relationship Between Self-Monitoring of Blood Glucose Control and Glycosylated Haemoglobin in Patients with Type 2 Diabetes with and Without Diabetic Retinopathy.” Journal of Diabetes and Its Complications, 2003.
B. R. Chaudhry, Ali Raza Balouch, and M. Hassan. “ASSOCIATION OF DIABETIC RETINOPATHY WITH INCREASED BLOOD LEVEL OF HBA1C.” Theoretical & Applied Science, 2020.
Bhasker Mukherjee, S. Shankar, R. Ahmed, Kanchan Singh, and K. Bhatia. “Association of Glycated Haemoglobin and Serum Apolipoproteins with Diabetic Retinopathy: An Indian Overview.” Journal of Clinical and Diagnostic Research : JCDR, 2017.
Bhoomika Khosya, and Devaraj Cg. “The Relationship Between Blood Sugar Levels (Glycosylated Haemoglobin) and the Risk of Development of Diabetic Retinopathy,” 2017.
Bin Wang, Hui Li, Lin Wang, and ZaiHong Chen. “Association of Hemoglobin-to-Red Cell Distribution Width Ratio with Diabetic Retinopathy Risk and Severity.” Frontiers in Endocrinology, 2025.
Bing Seng Wong, S. Sharanjeet-Kaur, N. Ngah, and Rajan Rajasudha Sawri. “The Correlation Between Hemoglobin A1c (HbA1c) and Hyperreflective Dots (HRD) in Diabetic Patients.” International Journal of Environmental Research and Public Health, 2020.
C. Bernal-Morales, A. Alé-Chilet, Ruben Martin-Pinardel, Marina Barraso, Teresa Hernandez, Cristian Oliva, I. Vinagre, et al. “Optical Coherence Tomography Angiography in Type 1 Diabetes Mellitus. Report 4: Glycated Haemoglobin.” Diagnostics, 2021.
C. Domngang, Alex Deffo, Stephanie Eyombo, O’Neal Youte, Leonard Tedong, Giles Kagmeni, and Eugene Sobngwi. “EVALUATION OF ENDOTHELIN-1 AND GLYCATED HAEMOGLOBIN IN TYPE 2 DIABETIC PATIENTS WITH AND WITHOUT RETINOPATHY.” International Journal of Retina, 2024.
C. Kullberg, and H. Arnqvist. “Good Blood Glucose Control Characterizes Patients Without Retinopathy After Long Diabetes Duration.” Diabetic Medicine, 1995.
C. Singh, Shashi Prabha Prasad, S. Kaul, Divya Motwani, Ashish Mishra, and Vishakh Padmakumar. “Association of HbA1c Levels with Diabetic Retinopathy.” Indian Journal of Clinical and Experimental Ophthalmology, 2021.
Celso Nabais, J. Pereira, P. Pereira, Rui Capote, Sheila Morbeck, and J. Raposo. “[Diabetic Retinopathy and Associated Conditions, What Relationship? A Study in Portuguese Patients with Type 2 Diabetes].” Acta Médica Portuguesa, 2011.
Chebly Dagher, M. Akiki, Rita Saliby, and Georges Harb. “The Impact of Glycemic Control on Ranibizumab Efficacy in Diabetic Retinopathy: A Retrospective Analysis.” Cureus, 2025.
Chhaya Verma. “INVERSE RELATION OF 25-OH VITAMIN D LEVEL WITH SEVERITY OF DIABETIC RETINOPATHY AND HBA1C IN TYPE 2 DIABETES PATIENTS: SUPPLEMENTATION MAY HALT SEVERITY.” Asian Journal of Pharmaceutical and Clinical Research, 2024.
D. Goldstein, K. Blinder, C. Ide, Roy J. Wilson, H. Wiedmeyer, R. Little, J. D. England, Mark Eddy, J. Hewett, and S. Anderson. “Glycemic Control and Development of Retinopathy in Youth-Onset Insulin-Dependent Diabetes Mellitus. Results of a 12-Year Longitudinal Study.” Ophthalmology (Rochester, Minn.), 1993.
D. McCance, A. Atkinson, D. Hadden, D. Archer, and Laurence Kennedy. “LONG-TERM GLYCAEMIC CONTROL AND DIABETIC RETINOPATHY.” The Lancet, 1989.
D. Ms. “Correlation Between Glycosylated Haemoglobin in Type 2 Diabetes Mellitus and Diabetic Retinopathy.” Journal of Medical Science And Clinical Research, 2022.
D. Schanzlin, W. Jay, K. J. Fritz, R. Tripathi, and B. Gonen. “Hemoglobin A1 and Diabetic Retinopathy.” American Journal of Ophthalmology-Glaucoma, 1979.
D. Tarasewicz, C. Conell, L. Gilliam, and R. Melles. “Quantification of Risk Factors for Diabetic Retinopathy Progression.” Acta Diabetologica, 2022.
Debasmita Mishra, Deshish Kumar Panda, Prasant Nanda, and Saiprasanna Behera. “A STUDY ON CLINICAL EVALUATION OF DIABETIC RETINOPATHY AND ITS CORRELATION WITH SERUM HbA1c LEVEL.” PARIPEX-INDIAN JOURNAL OF RESEARCH, 2021.
Deepasha Shahi Bagzai. “Correlation Between Severity of Diabetic Retinopathy with HbA1c in Type II Diabetic Patients.” Journal of Medical Science And Clinical Research, 2019.
Deepti Mujumdar, P. Varma, and Parth Rai. “CORRELATION OF DURATION OF DIABETES MELLITUS AND GLYCOSYLATED HAEMOGLOBIN (HBA1C) LEVELS WITH DIABETIC RETINOPATHY.” International Journal of Scientific Research, 2023.
Dr Hafsa Imran Khan, Dr Umer Mushtaq, Dr Fajar Khalid, Dr Maryam Aslam, Dr Muhammad Rohail Tariq, Dr Ayesha Shahzad, and Dr Muhammad Mustafa Imran. “CORRELATION OF Hba1C LEVELS WITH RETINAL CHANGES IN PATIENTS WITH DIABETIC RETINOPATHY.” Journal of Medical &Amp; Health Sciences Review, 2025.
Dr. Ikhlass Ali Hussein Al-Hilaly. “A Study of Diabetic Retinopathy in Type 2 Diabetic Patients and Its Relation with Diabetic Progression.” Al-Kufa University Journal for Biology, 2018.
E. Maddaloni, Angela Carlone, D. Pitocco, Giulia Leanza, C. Suraci, M. Altomare, M. Cavallo, et al. “471-P: Glycated Haemoglobin in the First Year After Diagnosis of Type 1 Diabetes Is an Independent Risk Factor for Diabetic Retinopathy: The IMDIAB 25 Years Follow-Up Study.” Diabetes, 2022.
E. Martín-Merino, J. Fortuny, E. Rivero-Ferrer, M. Lind, and L. García-Rodríguez. “Risk Factors for Diabetic Retinopathy in People with Type 2 Diabetes: A Case-Control Study in a UK Primary Care Setting.” Primary Care Diabetes, 2016.
F. Farhani, Zulfachmi Wahab, and Yanuarita Tursinawati. “Hubungan Antara Kadar HbA1c Dan Derajat Retinopati Pasien Diabetes Melitus Tipe 2 Di Rumah Sakit Mata Cicendo Bandung.” Jurnal Kesehatan Andalas, 2023.
F. Ganjifrockwala, J. Joseph, and G. George. “Evaluation of Kidney Function and Risk Factors of Retinopathy in Type 2 Diabetes Mellitus People in South Africa.” Diabetes Research and Clinical Practice, 2017.
Faeze Poshtchaman, Alemeh Dehnabi, Zahra Poshtchaman, and Batul Birjandi. “HbA1C, Proliferative and Non-Proliferative Retinopathy in Diabetic Patients.” Medicina Clínica Práctica, 2023.
Faisal Redwan. “Evaluation of the Relationship Between Hemoglobin A1c and Diabetic Retinopathy in Patients with Type Ⅱ Diabetes at Tishreen University Hospital- Latakia- Syria.” International Journal of Medical Sciences, 2024.
Febrina Art, A. Ansyori, and Ramzi Amin. “Relationship Between HbA1c Level with Retinal Nerve Fiber Layer Thickness in Diabetic Retinopathy.” Sriwijaya Journal of Ophthalmology, 2019.
Fei Qin, Limei Jing, L. Jia, Jieqiong Lou, Yi Feng, Wen Long, Hui Yang, and Rong Shi. “Retinopathy Among Chinese Subjects with Type 2 Diabetes Mellitus in Shanghai: A Community-Based Follow-up Study.” International Journal of Health Planning and Management, 2019.
Graham P. Leese. “Longitudinal Study Examining the Risk Factors for Proliferative Retinopathy and Maculopathy in Type-I Diabetes: The Royal College of Physicians of Edinburgh Diabetes Register Group.” Eye, 2004.
H. Funatsu, H. Yamashita, and Y. Ohashi. “[Relationship Between Progression of Diabetic Retinopathy and Blood Glucose Control].” Nippon Ganka Gakkai Zasshi, 1991.
H. Funatsu, H. Yamashita, Y. Ohashi, and T. Ishigaki. “Correlation Between Progression of Diabetic Retinopathy and Blood Glucose Control.” Japanese Journal of Ophthalmology, 1991.
H. Funatsu, S. Hori, Y. Ohashi, and T. Ishigaki. “[Risk Factors for Occurrence and Progression of Diabetic Retinopathy].” Nippon Ganka Gakkai Zasshi, 1993.
H. Hwang, Jin Young Kim, T. Oh, J. Chae, and D. Kim. “Relationship Between Clinical Features of Diabetic Retinopathy and Systemic Factors in Patients with Newly Diagnosed Type II Diabetes Mellitus.” Journal of Korean Medical Science, 2020.
H. Khan, Shahum Khan, Akhunzada Aftab Ahmed, Haris Ashfaq, Adnan Ali, and Adeela Mustafa. “Prevalence of Diabetic Retinopathy and Correlation with HbA1c in Patients Admitted in Khyber Teaching Hospital..” 2021.
Han Ul Kim, S. Park, and Yong-Kyu Kim. “Long-Term HbA1c Variability and the Development and Progression of Diabetic Retinopathy in Subjects with Type 2 Diabetes.” Scientific Reports, 2021.
“HbA1c and Serum Level of VEGF in Diabetic Retinopathy Patients.” Indian Journal of Forensic Medicine &Amp; Toxicology, 2022.
Hong-Kyu Kim, Chulhyun Kim, Sang-Wook Kim, J. Park, S. Hong, Y. Yoon, and Ki-Up Lee. “Development and Progression of Diabetic Retinopathy in Koreans With NIDDM.” Diabetes Care, 1998.
Hong-Xia Zhang, L. Jia, X. Hou, Jun-xi Lu, Hui‐juan Lu, Jie Du, Huilin Gu, and W. Jia. “[Prevalence of and Risk Factors Associated with Diabetic Retinopathy in Pre-Diabetic and Diabetic Population in Shanghai Community].” Zhonghua Yi Xue Za Zhi, 2009.
Hoyam Yousif Hussin Alimam, Waleed Abdelateif Hussein, S. Ibrahim, Sara Abdelgani, Nahed S. Alharthi, Lienda Bashier Eltayeb, Salih Abdelgadir Elmahdi, and AbdElkarim Abobakr Abdrabo. “Blood Glucose, HbA1c Level, and Its Correlation with VEGF-A (+405G/C) Polymorphism as Biomarker Predicts the Risk of Retinopathy and Nephropathy in Type 2 Diabetic Patients.” Reports of Biochemistry and Molecular Biology, 2022.
I. Chatziralli, T. Sergentanis, R. Crosby-Nwaobi, Kirsty Winkley, H. Eleftheriadis, K. Ismail, S. Amiel, and S. Sivaprasad. “Model for Risk-Based Screening of Diabetic Retinopathy in People With Newly-Diagnosed Type 2 Diabetes Mellitus.” Investigative Ophthalmology and Visual Science, 2017.
Irma Yanti Rangkuti. “Hubungan Antara Diabetes Melitus Tipe 2 Dengan Retinopati Diabetik Dikaji Dari HbA1c Sebagai Parameter Kontrol Gula Darah,” 2011.
“Is There a Relationship Between Diabetic Retinopathy and Vitamin D?” The Annals of Clinical and Analytical Medicine, 2023.
J. Bower, F. Brancati, and E. Selvin. “No Ethnic Differences in the Association of Glycated Hemoglobin With Retinopathy.” Diabetes Care, 2013.
J. Hermann, H. Hammes, B. Rami-Merhar, J. Rosenbauer, M. Schütt, E. Siegel, and R. Holl. “HbA1c Variability as an Independent Risk Factor for Diabetic Retinopathy in Type 1 Diabetes: A German/Austrian Multicenter Analysis on 35,891 Patients.” PLoS ONE, 2014.
J. Nasser, F. Habib, Basma Al Tajer, Maha Al Tajer, and Fatima Juma. “Risk Factors for Diabetic Retinopathy in Patients Attending Primary Care Settings,” 2014.
J. P. Monson, G. Koios, G. Toms, P G Kopelman, B J Boucher, S. Evans, and W L Alexander. “Relationship Between Retinopathy and Glycaemic Control in Insulin-Dependent and Non-Insulin-Dependent Diabetes.” Journal of the Royal Society of Medicine, 1986.
J. Setareh, Ghazale Hoseinzade, B. Khoundabi, M. Kamali, Ata Ebrahimi, Andarz Fazlollahpour-Naghibi, Mohammad Zareei, Mona Mohamaditabar, and Ali Makaremi. “Can the Level of HbA1C Predict Diabetic Retinopathy Among Type II Diabetic Patients?” BMC Ophthalmology, 2022.
J. Yoon, S. Baek, and Young Hoon Lee. “Risk Factor Analysis of Diabetic Retinopathy Diagnosed with Non-Mydriatic Fundus Camera: KNHANES V.” Journal of the Korean Ophthalmological Society, 2019.
Jennifer Perais, Ridhi Agarwal, J. Evans, E. Loveman, J. Colquitt, David Owens, R. Hogg, J. Lawrenson, Y. Takwoingi, and N. Lois. “Prognostic Factors for the Development and Progression of Proliferative Diabetic Retinopathy in People with Diabetic Retinopathy.” Cochrane Database of Systematic Reviews, 2020.
Jiaqi Hu, H. Hsu, Xiaodan Yuan, Kezheng Lou, Cunyi Hsue, Joshua D. Miller, Ju-ming Lu, Yau-Jiunn Lee, and Qingqing Lou. “HbA1c Variability as an Independent Predictor of Diabetes Retinopathy in Patients with Type 2 Diabetes.” Journal of Endocrinological Investigation, 2020.
Jie Xuan, Liqin Wang, Liqi Fan, and Shuxing Ji. “Systematic Review and Meta-Analysis of the Related Factors for Diabetic Retinopathy.” Annals of Palliative Medicine, 2022.
Joshi, Lavaju, B. Badhu, Maskey, and Lamsal. “Study of Biochemical Parameters in Diabetic Patients with and Without Diabetic Retinopathy – A Hospital Based Study.” Journal of Diabetes and Endocrinology Association of Nepal, 2021.
Juan Ling, Zhuolin Xie, XiaoJie Chen, Di Ling, Xinglin Chen, and Xiangxia Luo. “Inverted U-Shaped Relationship Between HbA1c and Diabetic Retinopathy in Diabetic Patients: A Cross-Sectional Study.” BMC Ophthalmology, 2025.
Jun Liu, Miao Yu, Jingyu Yan, Wei Chen, Pei Zhang, Yuchen Wang, Huijin Chen, and Jinping Hu. “The Association Between Glycated Hemoglobin and Intraocular Inflammatory Factors in Patients with Proliferative Diabetic Retinopathy.” International Journal of Retina and Vitreous, 2025.
K. Alabdulwahhab. “Relationship Between Diabetic Retinopathy and HbA1c in Type 2 Diabetics, Kingdom of Saudi Arabia,” 2019.
K. Aziz. “ASSOCIATION BETWEEN HIGH RISK FOOT, RETINOPATHY AND HbA1c IN SAUDI DIABETIC POPULATION,” 2010.
———. “Association of Diabetic Retinopathy and Maculopathy with Elevated HbA1c, Blood Pressure, Serum Creatinine, Microalbuminuria, Spot Urine Protein, Nephropathy and Diabetic Kidney Disease. An Experience from Data Analysis of 10,580 Diabetic Patients,” 2018.
K. Kalaivani. “RISK FACTORS FOR DIABETIC RETINOPATHY IN TYPE 2 DIABETES MELLITUS PATIENTS.” Journal of Medical Pharmaceutical and Allied Sciences, 2021.
K. Karadayı, C. Top, and O. Gülecek. “The Relationship Between Soluble L-Selectin and the Development of Diabetic Retinopathy.” Ocular Immunology and Inflammation, 2003.
K. Karakuş, H. Akturk, Janet K. Snell-Bergeon, and Viral N. Shah. “Progression of Diabetic Retinopathy After Initiation of Automated Insulin Delivery System in Adults With Type 1 Diabetes.” Journal of Diabetes Science and Technology, 2025.
K. Klausen, K. Borch-Johnsen, and B. Feldt-Rasmussen. “Preventive Cardiology: abstractVery Low Levels of Microalbuminuria Are Associated with Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes☆,” 2004.
K. Nishant, P. Rai, Sujata Kumari, and Nageshwar Sharma. “The Relationship Between Glycosylated Haemoglobin (Hba1c) Levels and Diabetic Retinopathy in Type 2 Diabetes: A Cross- Sectional Study,” 2021.
K. S., Binu S.S, and Bhaskar M.K. “An Observational Study on the Association Between Diabetic Retinopathy and Serum Lipid Levels in a Tertiary Centre in Thiruvananthapuram.” Journal of Evidence Based Medicine and Healthcare, 2021.
K. Shakya, J K Shrestha, and S. N. Joshi. “Association Between Diabetic Retinopathy and Serum Lipoproteins Level.” Nepalese Journal of Ophthalmology, 2010.
K. S., Jayalekshmi T., M. S., and P. M. “Effect of Glycemic Control on Diabetic Retinopathy and Diabetic Macular Edema: A Prospective Observational Study.” International Journal of Advances in Medicine, 2021.
Kainaat Talat, Tariq Munawar, Muhammad Fahad Ikram, Shehar Bano, and Abdul Rafeh. “CORRELATION OF HBA1C LEVEL WITH DIABETIC RETINOPATHY.” Journal of Ayub Medical College, 2025.
Kalpna Jain, Suman Devi, Poonam Bhargava, Lakshita Maherda, and D. Yadav. “Association of Glycosylated Hemoglobin (HbA1C) Level with Diabetic Retinopathy in Type 2 Diabetes Patients at Tertiary Care Hospital.” International Journal of Ophthalmology Sciences, 2020.
Kelvin K. K. Ng, C. Cheung, C. Lee, C. Fong, K. Kwok, Kenneth K. W. Li, R. Gangwani, et al. “Possible Modifying Effect of Hemoglobin A1c on Genetic Susceptibility to Severe Diabetic Retinopathy in Patients With Type 2 Diabetes.” Investigative Ophthalmology and Visual Science, 2020.
L. S., and S. S. “Study of HbA1C Levels in Patients with Type 2 Diabetes Mellitus in Relation to Diabetic Retinopathy in Indian Population.” International Journal of Advances in Medicine, 2018.
L. Zhai, Jun Lu, Xin Cao, Jun Zhang, Yong Yin, and Huiping Tian. “Association Between the Variability of Glycated Hemoglobin and Retinopathy in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis.” Hormone and Metabolic Research, 2022.
Liying Zhang, G. Krzentowski, A. Albert, and P. Lefèbvre. “Risk of Developing Retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients with Good or Poor Metabolic Control.” Diabetes Care, 2001.
M. Chen, C. Kao, Chen-Chung Fu, Chien-Jen Chen, and T. Tai. “Incidence and Progression of Diabetic Retinopathy Among Non-Insulin-Dependent Diabetic Subjects: A 4-Year Follow-up.” International Journal of Epidemiology, 1995.
M. Goyal, P. Kamboj, J. Behgal, and S. Lather. “Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus,” 2017.
M. Gulliford, H. Dodhia, S. Sivaprasad, and M. Ashworth. “Family Practices' Achievement of Diabetes Quality of Care Targets and Risk of Screen-Detected Diabetic Retinopathy.” PLoS ONE, 2010.
M. Henricsson, K. Berntorp, E. Berntorp, P. Fernlund, and G. Sundkvist. “Progression of Retinopathy After Improved Metabolic Control in Type 2 Diabetic Patients. Relation to IGF-1 and Hemostatic Variables.” Diabetes Care, 1999.
M. Kotoula, G. Koukoulis, E. Zintzaras, C. H. Karabatsas, and D. Chatzoulis. “Metabolic Control of Diabetes Is Associated with an Improved Response of Diabetic Retinopathy to Panretinal Photocoagulation.” Diabetes Care, 2005.
M. Lind. “Glycaemic Control: Evaluation of HbA1c as a Risk Factor and the Effect of Modern Insulins in Clinical Practice,” 2009.
M. Lind, A. Pivodic, A. Svensson, A. F. Ólafsdóttir, H. Wedel, and J. Ludvigsson. “HbA1c Level as a Risk Factor for Retinopathy and Nephropathy in Children and Adults with Type 1 Diabetes: Swedish Population Based Cohort Study.” British Medical Journal, 2019.
M. Martínez, J. Otero, Oleydis Brizuela Labrada, Hugo Norge Santisteban Sánchez, and A. Zamora. “Valor Pronóstico de La Hemoglobina Glicada HbA1c En El Padecimiento de Retinopatía Diabética En Pacientes Con Diabetes Mellitus Tipo II,” 2020.
M. Mjwara, M. Khan, C. Kruse, W. Sibanda, and C. Connolly. “Significance of HbA1c Levels in Diabetic Retinopathy Extremes in South Africa.” South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde, 2021.
M. Petrović, B. Veljković, Katarina M. Janicijevic, and T. Vulović. “Correlation Between Metabolic Controls and Changes in Retina in Patients Having Diabetes.” Medicinski Pregled, 2014.
Marwa Riyadh Khalaf, Mutaz Ahmeid, and Osamah Jihad Abdulqader Hashim Abdulsattar Jabar. “Evaluation the Role of Malondialdehyde in Occurrence and Development of Diabetic Retinopathy Patients.” Medico-Legal Update, 2021.
Min Long, Cong Wang, and Dongfang Liu. “Glycated Hemoglobin A1C and Vitamin D and Their Association with Diabetic Retinopathy Severity.” Nutrition & Diabetes, 2017.
Muhammad Asif, Fazal Noman, Samina Karim, and Javed Rasul. “Association of Severity of Diabetic Retinopathy with HbA1c Level.” Ophthalmology Pakistan, 2024.
Munish Dhawan, S. Singh, and Karan Badhan. “To Study the Correlation of Diabetic Retinopathy with Glycosylated Haemoglobin and Body Mass Index in Type II Diabetes.” Indian Journal of Clinical and Experimental Ophthalmology, 2019.
N. Cho, Tae Hyuk Kim, S. Woo, Kyungil Park, Soo Lim, Y. Cho, K. Park, H. Jang, and S. Choi. “Optimal HbA1c Cutoff for Detecting Diabetic Retinopathy.” Acta Diabetologica, 2013.
N. Meena, H. Meena, and Manizha Meena. “CORRELATION OF BLOOD SUGAR AND HBA1C LEVELS IN DIFFERENT STAGES OF DIABETIC RETINOPATHY AT OUR TERTIARY CARE CENTER IN AJMER,” 2019.
N. White, Q. Pan, W. Knowler, Emily B. Schroeder, D. Dabelea, E. Chew, B. Blodi, et al. “Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience.” Diabetes Care, 2022.
Na Li, Xiu-fen Yang, Yu Deng, H. Gu, X. Ren, Jun Xu, Kai Ma, and N. Liu. “[Diabetes Self-Management and Its Association with Diabetic Retinopathy in Patients with Type 2 Diabetes].” [Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology, 2013.
Nadia Ghassan Abdulkareem, Najlaa Abed Jassim, Zahraa Kadhim Mohammed, and Muzahim Alkabban. “Linkage Between the Duration of Diabetes Mellitus Type-2 with the Biochemical Measurements and the Extent of Chronic Complications.” Journal of Bioscience and Applied Research, 2024.
Nafisa Marzan Chowdhury, Salma Akhter, Mohammad Taufiq ul Alam, Ayesha Mahzabin Chowdhury, Taposhi Farzana, and Sheikh Khadija. “Association of Diabetic Retinopathy with Duration of Type 2 Diabetes Mellitus and Glycemic Control.” Central Medical College Journal, 2025.
Nayef Alswaina. “Association Between HbA1c Levels and the Severity of Diabetic Retinopathy.” Cureus, 2024.
Nikhilesh A. Badiani, Jigish Desai, Shilpa B. Bhatt, Mittal G Kuchhadiya, Bhargavi Parth, Khushi Shah, Vishal Parikh, and Mitesh Rathod. “CORRELATION BETWEEN GLYCOSYLATED HAEMOGLOBIN (HBA1C) LEVEL AND MACULAR THICKNESS IN TYPE 2 DIABETIC PATIENTS IN TERTIARY CARE TEACHING HOSPITAL.” Global Journal For Research Analysis, 2025.
Niveditha H, Yogitha C, Liji P, S. Shetty, Himamshu N.V.V., Vinutha B.V, and Pooja Patil. “CLINICAL CORRELATION OF HBA1C AND DIABETIC NEPHROPATHY WITH DIABETIC RETINOPATHY,” 2013.
Noel Wat, R. Wong, and Ian YH Wong. “Associations Between Diabetic Retinopathy and Systemic Risk Factors.” Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi, 2016.
Noura M Almutairi, Shoroog Alahmadi, M. Alharbi, Sarah Gotah, and M. Alharbi. “The Association Between HbA1c and Other Biomarkers With the Prevalence and Severity of Diabetic Retinopathy.” Cureus, 2021.
Nutan Bedi, A. Gulati, and Gauri V. Devasthali. “Correlative Study of Diabetic Retinopathy in Type 2 Diabetes Mellitus with Haemoglobin A1c, Duration of Diabetes and Modifiable Risk Factors: Smoking, Alcohol and BMI in Adult Population Attending a Tertiary Care Hospital.” International Journal of Research in Medical Sciences, 2021.
O. Brinchmann‐Hansen, K. Dahl-Jørgensen, Leiv Sandvik, and Kristian F. Hanssen. “Blood Glucose Concentrations and Progression of Diabetic Retinopathy: The Seven Year Results of the Oslo Study.” British Medical Journal, 1992.
Orijinal Makale, Feyzullah Güçlü, S. Kafesçiler, D. Özmen, and Z. Hekimsoy. “The Relationship Between Glycosylated Haemoglobin and Diabetic Retinopathy in Patients with Type 2 Diabetes Tip 2 Diabetes,” 2007.
P. Garg, S. Misra, S. Yadav, and L. Singh. “Correlative Study of Diabetic Retinopathy with HbA1c and Microalbuminuria,” 2018.
P. Geetha, and P. Shanmugasundaram. “A Prospective Observational Study on Assessment of Risk Factor Associated with Diabetic Retinopathy in Patients Diagnosed with Type 2 Diabetes Mellitus in South Indian Population.” Research Journal of Pharmacy and Technology, 2019.
P. K. V. Sai Akshay, Mohan Lal Pandey, and Harsh Raj Nehra. “ASSOCIATION BETWEEN GLYCOSYLATED HEMOGLOBIN (HBA1C), DURATION OF DIABETES AND SEVERITY OF DIABETIC RETINOPATHY IN TYPE 2 DIABETES MELLITUS PATIENTS ATTENDING A TERTIARY HEALTH CARE CENTER IN NORTHERN INDIA.” PARIPEX-INDIAN JOURNAL OF RESEARCH, 2025.
P. Kiran, and B. Srinivas. “Study of Glycated Haemoglobin , Lipid Profile and Uric Acid Levels in Diabetic Retinopathy,” 2015.
P. Lam, S. Chow, W. Lam, Loraine Lok Wan Chow, and N. S. Fung. “OPTH_A_301317 2767..2785,” 2021.
P. Romero Aroca, M. Salvat Serra, I. Méndez Marín, and I. Martínez Salcedo. “[Is Microalbuminuria a Risk Factor for Diabetic Retinopathy?].” Journal Francais d'Ophtalmologie, 2003.
P. Romero-Aroca, M. Baget-Bernaldiz, Javier Reyes-Torres, Juan Fernández-Ballart, Nuria Plana-Gil, I. Méndez-Marín, and A. Pareja-Ríos. “Relationship Between Diabetic Retinopathy, Microalbuminuria and Overt Nephropathy, and Twenty-Year Incidence Follow-up of a Sample of Type 1 Diabetic Patients.” Journal of Diabetes and Its Complications, 2012.
P. Romero-Aroca, M. Baget-Bernaldiz, Juan Fernández-Ballart, Nuria Plana-Gil, N. Soler-Lluís, I. Méndez-Marín, and Ángel Bautista-Pérez. “Ten-Year Incidence of Diabetic Retinopathy and Macular Edema. Risk Factors in a Sample of People with Type 1 Diabetes.” Diabetes Research and Clinical Practice, 2011.
P. Romero-Aroca, Raquel Verges, Jordi Pascual-Fontanilles, Aida Valls, J. Franch, J. Barrot, Xavier Mundet, et al. “Effect of Lipids on Diabetic Retinopathy in a Large Cohort of Diabetic Patients After 10 Years of Follow-Up.” Journal of Clinical Medicine, 2023.
P. Romero, M. Salvat, Juan Fernández, M. Baget, and Inmaculada Martinez. “Renal and Retinal Microangiopathy After 15 Years of Follow-up Study in a Sample of Type 1 Diabetes Mellitus Patients.” Journal of Diabetes and Its Complications, 2007.
P. Sharma, Kavita Kumar, Aditi Dubey, Nitin Kushwaha, and Pooja Maravi. “Clinical Study on Association of Diabetic Retinopathy Severity with HbA1c Level.” Indian Journal of Clinical and Experimental Ophthalmology, 2024.
P. Tangjai, Preerati Chingchana, and Rutchapom Taweerutchana. “Glycated Haemoglobin and Diabetic Retinopathy in Type 2 Diabetic Patients in HRH Princess Maha Chakri Sirindhorn Medical Center.” Journal of the Medical Association of Thailand = Chotmaihet Thangphaet, 2015.
Patcharapol Wittayatechakul, Paniti Hanyos, R. Rangsin, and B. Sakboonyarat. “INCIDENCE AND RISK FACTORS OF DIABETIC RETINOPATHY AMONG PATIENTS WITH TYPE 2 DIABETES IN A COMMUNITY HOSPITAL, CENTRAL THAILAND.” Journal of Southeast Asian Medical Research, 2021.
Peiyao Jin, Jin-juan Peng, H. Zou, Weiwei Wang, Jiong Fu, B. Shen, X. Bai, Xun Xu, and Xi Zhang. “A Five-Year Prospective Study of Diabetic Retinopathy Progression in Chinese Type 2 Diabetes Patients with “Well-Controlled” Blood Glucose.” PLoS ONE, 2015.
Penugonda Anveetha, and Vamsi Krishna Chittimoju. “Study of HbA1c and Serum Magnesium in Diabetic Patients with Retinopathy,” 2021.
Pipit Chandra, Sri Rejeki Budi Rahayu, and E. Ms. “HUBUNGAN ANTARA HbA1C DENGAN TINGKAT KEPARAHAN RETINOPATI DIABETIKA PADA PASIEN DM DI KLINIK MATA NUSANTARA JAKARTA.” Jurnal Sains Kesehatan, 2022.
Poojyashree Karki, M. J. Sijapati, P. Basnet, and Anjila Basnet. “Prevalence of Dry Eyes Syndrome and Retinopathy in Diabetic Patients and the Association of Glycosylated Hemoglobin with Retinopathy.” Journal of Pathology of Nepal, 2018.
Puneeth Hegde, A. Rani, and V. Pai. “Correlation of Risk Factors with Severity of Diabetic Retinopathy - A Retrospective Study,” 2020.
Putri Lenggo Geany, Riski Prihatningtias, Arief Wildan, and Maharani Cahyono. “Correlation Between HbA1c Levels and Severity of Diabetic Retinopathy.” Jurnal Kedokteran Diponegoro, 2022.
Qingmin Sun, Y. Jing, Bingjie Zhang, T. Gu, R. Meng, Jie Sun, Dalong Zhu, and Yaping Wang. “The Risk Factors for Diabetic Retinopathy in a Chinese Population: A Cross-Sectional Study.” Journal of Diabetes Research, 2021.
R. Abiramasundari, and K. Latha. “Glycemic Control and the Microvascular Outcome “Retinopathy” in Patients with Type 2 Diabetes Mellitus,” 2020.
R. axer-siegel, Z. Herscovici, M. Gabbay, K. Mimouni, D. Weinberger, and U. Gabbay. “The Relationship Between Diabetic Retinopathy, Glycemic Control, Risk Factor Indicators and Patient Education.” The Israel Medical Association Journal : IMAJ, 2006.
R. Giansanti, M. Boemi, L. Amodio, P. Fioravanti, R. Rabini, and P. Fumelli. “Long-Term Metabolic Control and Retinopathy in Type I Diabetes: Ten-Year Follow-up.” Diabetes Research (Edinburgh, Scotland), 1994.
R. Klein, B. Klein, S. Moss, and K. Cruickshanks. “Relationship of Hyperglycemia to the Long-Term Incidence and Progression of Diabetic Retinopathy.” Archives of Internal Medicine, 1994.
R. Klein, B. Klein, S. Moss, M. Davis, and D. DeMets. “Glycosylated Hemoglobin Predicts the Incidence and Progression of Diabetic Retinopathy.” Journal of the American Medical Association (JAMA), 1988.
R. Raman, Aditi Gupta, V. Kulothungan, and T. Sharma. “Prevalence and Risk Factors of Diabetic Retinopathy in Subjects with Suboptimal Glycemic, Blood Pressure and Lipid Control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33).” Current Eye Research, 2012.
R. Raman, Aditya Verma, S. S. Pal, Aditi Gupta, K. Vaitheeswaran, and T. Sharma. “Influence of Glycosylated Hemoglobin on Sight-Threatening Diabetic Retinopathy: A Population-Based Study.” Diabetes Research and Clinical Practice, 2011.
R. Simó, J. Franch-Nadal, B. Vlacho, J. Real, Ester Amado, Juana Flores, M. Mata-Cases, et al. “Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-World Population-Based Study in Subjects With Type 2 Diabetes.” Diabetes Care, 2023.
Raja Muhammad Taimoor Khan, Haroon Saleem, S. Bhatti, M. U. Sadiq, and M. I. Sadiq. “Association of Severity of Diabetic Retinopathy with Levels of HbA1c.” Pakistan Journal of Medical & Health Sciences, 2022.
Rajarshi As, K. Chatterjee, Moumita Mandal, and S. Sarkar. “A Cross-Sectional Study on Association Between Diabetic Retinopathy and Glycated Hemoglobin Level Among Type 2 Diabetes Mellitus Patients in a Tertiary Care Hospital of Kolkata.” National Journal of Physiology Pharmacy and Pharmacology, 2021.
Rebecka Andreasson, C. Ekelund, M. Landin-Olsson, and Charlotta Nilsson. “HbA1c Levels in Children with Type 1 Diabetes and Correlation to Diabetic Retinopathy.” Journal of Pediatric Endocrinology & Metabolism (JPEM), 2018.
Rehna Rasheed, Gopal S. Pillai, H. Kumar, A. Shajan, N. Radhakrishnan, and G. Ravindran. “Relationship Between Diabetic Retinopathy and Diabetic Peripheral Neuropathy - Neurodegenerative and Microvascular Changes.” Indian Journal of Ophthalmology, 2021.
Rui-fang Feng, Haiyang Liu, Yalu Liu, Qing Xu, Lei Qiao, Chaochao Gong, Yipeng Zhang, et al. “Diabetes Onset at an Earlier Age and High HbA1c Levels as Risk Factors of Diabetic Retinopathy.” International Journal of Ophthalmology, 2021.
S. A. Alghamdi, Ayla M Tourkmani, Turki J. Alharbi, A. B. Rsheed, and Wedad Almadani. “Prevalence of Retinopathy and Associated Risk Factors Among High- and Low-Risk Patients with Type 2 Diabetes Mellitus.” Saudi Medical Journal, 2021.
S. A. Gardezi, N. K. Niazi, S. H. Tirmizi, I. Rafique, Rabia Sadiq, M. Rehman, and T. Laique. “Co-Relation of HBA1C Level with Diabetic Retinopathy on Fundoscopy in Patients Suffering from Type-II DM for More Than 10 Years Duration.” Pakistan Journal of Medical & Health Sciences, 2022.
S. A. Rasoulinejad, N. Meftah, M. S. Maniati, and M. Maniati. “High Levels of FBS and HbA1c and Their Association with Diabetic Retinopathy: A Study in the North of Iran.” Journal of Diabetes and Metabolic Disorders, 2022.
S. Hoque, Muttalib Ma, Imtiajul Islam, P. Khanam, and S. Choudhury. “Evaluation of HbA1c Level and Other Risk Factors in Diabetic Retinopathy: A Study of Type 2 Diabetic Patients Attending in a Tertiary Level Hospital,” 2017.
S. Kadu, Kishor Pandurang Kadu, Vishakha Vatkar, and Sharayu Ashok Bhore. “The Relationship Of Glycaemic Exposure (HbA1C) As Risk Factor For Development Of Diabetic Retinopathy,” 2021.
S. Kawasaki, Haruo Misawa, Y. Tamura, Yoshinobu Kondo, S. Satoh, O. Hasegawa, S. Kato, and Y. Terauchi. “Relationship Between Coronary Artery Disease and Retinopathy in Patients with Type 2 Diabetes Mellitus.” Internal Medicine, 2013.
S. Sewak. “Association of Level of HbA1c with Severity of Diabetic Retinopathy,” 2018.
S. Shaikh, A. Memon, M. Ata, Hina, and H. K. Khoharo. “Association of Serum Bilirubin, Serum Malondialdehyde and Glycemic Control with Retinopathy in Type 2 Diabetic Subjects,” 2017.
S. Sheu, N. Liu, L. Ger, W. Ho, Jiun-Yo Lin, Shih-Chou Chen, Yu-Harn Horng, and H. Lam. “High HbA1c Level Was the Most Important Factor Associated with Prevalence of Diabetic Retinopathy in Taiwanese Type II Diabetic Patients with a Fixed Duration.” Graefe's Archive for Clinical and Experimental Ophthalmology, 2013.
Saba Eqbal. “HbA1C Levels and Its Correlation in Diabetic Retinopathy.” Journal of Medical Science And Clinical Research, 2020.
Saba Izhar, Awais Amjad, and Seemi Habib. “Association of HbA1c with Diabetic Retinopathy in Diabetic Patients.” Annals of King Edward Medical University, 2025.
Saima Jamshed, A. Hanif, I. Malik, Nukhba Zahid, and Hafiza Sadia Imtiaz. “Relationship Between HbA1c Levels and Severity of Diabetic Retinopathy.” Pakistan Journal of Ophthalmology, 2021.
Sang Doan, Quang Minh Vo, and Khanh Linh Duong Ha. “Association Between HbA1c Level and Retinal Nerve Fiber Layer Thickness in Non-Proliferative Diabetic Retinopathy.” Tạp Chí Y Học Việt Nam, 2025.
Savan Shah, M. Feher, A. McGovern, J. Sherlock, M. Whyte, N. Munro, W. Hinton, P. Gatenby, and S. de Lusignan. “Diabetic Retinopathy in Newly Diagnosed Type 2 Diabetes Mellitus: Prevalence and Predictors of Progression; A National Primary Network Study.” Diabetes Research and Clinical Practice, 2021.
Sean M Rodriguez, Eric B Hamill, Amritha Sundaresan, Danielle Guffey, and Christina Y. Weng. “Comparing Teleretinal Screening-Identified Diabetic Retinopathy With Diabetic Nephropathy and Other Markers of Systemic Disease.” International Ophthalmology Clinics, 2018.
Shenglan Yang, Hui Liu, Yao Liang, Lijing Wu, Qidong Zheng, and Jing Wu. “Association Between Glycated Hemoglobin and Diabetic Retinopathy in Individuals with Diabetes: A Focus on the Modifying Effect of Ambulatory Blood Pressure.” Clinical Interventions in Aging, 2025.
Shubhaa Chawla, Siddhant Trehan, A. Chawla, S. Jaggi, R. Chawla, Vinay Kumar, and Depender Singh. “Relationship Between Diabetic Retinopathy Microalbuminuria and Other Modifiable Risk Factors.” Primary Care Diabetes, 2021.
Shuqi Wang, Xiaoyu Pan, Mengmeng Zhang, and Shuchun Chen. “Correlation Between Glycolipid Metabolism Levels and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.” Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy, 2024.
Sidda Naik Bukke, Ramachandram Badugu, Ramachandraiah Gurapa, Sree Pushpa Vani Gopavaram, and Rama Thulasi Bukkacherla. “Clinical Study on Correlation of HbA1c with Different Grades of Diabetic Retinopathy at S.V.R.R.G.G.H, Tirupati – A Hospital Based Descriptive Correlative Study.” Journal of Evidence Based Medicine and Healthcare, 2021.
Srinivas Phani Nakkella. “Association of Diabetic Retinopathy in Relation with HbA1c Levels,” 2019.
T. Bulum, M. Tomić, R. Vrabec, N. Brkljačić, and S. Ljubic. “Systolic and Diastolic Blood Pressure Are Independent Risk Factors for Diabetic Retinopathy in Patients with Type 2 Diabetes.” Biomedicines, 2023.
T. Chiu, Tien-Lung Tsai, Meifang Su, Tsan Yang, P. Tseng, Yau-Jiunn Lee, and Chao-Hsien Lee. “The Related Risk Factors of Diabetic Retinopathy in Elderly Patients with Type 2 Diabetes Mellitus: A Hospital-Based Cohort Study in Taiwan.” International Journal of Environmental Research and Public Health, 2021.
T. Chou, P.-C. Wu, J. Kuo, Chien-Hsiung Lai, and Chien-Neng Kuo. “Relationship of Diabetic Macular Oedema with Glycosylated Haemoglobin.” Eye, 2009.
T. Nakagami, R. Kawahara, S. Hori, and Y. Omori. “Glycemic Control and Prevention of Retinopathy in Japanese NIDDM Patients: A 10-Year Follow-up Study.” Diabetes Care, 1997.
“The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial.” Diabetes, 1995.
Tianyao Zhang, and Xu-Min Zheng. “Association of GA/HbA1c Ratio with Diabetic Retinopathy.” International Journal of Clinical Medicine, 2023.
Uddhav S. Khaire, Anupam Pal, Rahul Rathod, and Sayed Ammaruddin Chishty. “The Association of Diabetic Retinopathy with Fasting, Postprandial Blood Sugar Levels and Hba1C in Diabetes Mellitus Patients.” International Journal of Science and Research (IJSR), 2022.
V. H. R., S. Natesh, and Sudhir R. Patil. “Association Between Diabetic Retinopathy and Chronic Periodontitis—A Cross-Sectional Study.” Medical Science, 2018.
V. Malani, T. Sangeetha, BO Hanumanthappa, K. Athish, and Raheel Mohamed. “Relationship Between Glycosylated Haemoglobin Levels and Macular Thickness on Optical Coherence Tomography in Type 2 Diabetic Patients: A Cross-Sectional Study.” Journal of Clinical and Diagnostic Research, 2023.
Vandana Parasar, and Igims Patna Resident Rio. “To Evaluate the Relationship of HbA1c Levels and Serum Magnesium in Patients with Type II Diabetes and Its Correlation with Diabetic Retinopathy.” Journal of Medical Science And Clinical Research, 2019.
Vuyyuru Sri Durga, G. Premalatha, and K. Padmavathi. “CORRELATION OF RISK FACTORS WITH SEVERITY OF DIABETIC RETINOPATHY.” Asian Journal of Pharmaceutical and Clinical Research, 2022.
W. Shiferaw, T. Akalu, Melaku Desta, A. Kassie, P. Petrucka, H. Assefa, and Y. Aynalem. “Glycated Hemoglobin A1C Level and the Risk of Diabetic Retinopathy in Africa: A Systematic Review and Meta-Analysis.” Diabetes & Metabolic Syndrome, 2020.
Won Seon Jeon, Se Eun Park, E. Rhee, Won-Young Lee, K. Oh, Sung-woo Park, and Cheol-Young Park. “The Association of Serum Glycated Albumin with the Prevalence of Diabetic Retinopathy in Korean Patients with Type 2 Diabetes Mellitus.” Diabetes Research and Clinical Practice, 2016.
Xiaohua Wan, Ruihuan Zhang, Adilan Abudukeranmu, Wei Wei, Hong-Ting Zhu, Lin Zhang, and Yanwei Hu. “Elevated Triglyceride-Glucose Index as a Risk Stratification Marker for Diabetic Retinopathy in Type 2 Diabetes Mellitus: The Influence of Glycemic Control.” Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy, 2025.
Xinyin Xu, Wei Yang, Yin Deng, Ling Liu, Xin Zhang, Chengxu Long, T. Dong, Jing Zeng, Ji Kui, and Xian-ping Wu. “Association of Socioeconomic Status with Glycated Haemoglobin Level and Risk Factors for Diabetic Retinopathy: A Cross-Sectional Study in Sichuan, Western China.” BMJ Open, 2023.
Y. Matsushita, N. Takeda, Yosuke Nakamura, Natsuyo Yoshida-Hata, S. Yamamoto, Mitsuhiko Noda, T. Yokoyama, T. Mizoue, and T. Nakagawa. “A Comparison of the Association of Fasting Plasma Glucose and HbA1c Levels with Diabetic Retinopathy in Japanese Men.” Journal of Diabetes Research, 2020.
Y. Park, Seung-Hyun Ko, Jung-Min Lee, D. Kim, Dong-Joon Kim, Kyungdo Han, J. Bower, and Y. Ahn. “Glycaemic and Haemoglobin A1c Thresholds for Detecting Diabetic Retinopathy: The Fifth Korea National Health and Nutrition Examination Survey (2011).” Diabetes Research and Clinical Practice, 2014.
Y. Sato, Z. Lee, and Y. Hayashi. “Subclassification of Preproliferative Diabetic Retinopathy and Glycemic Control: Relationship Between Mean Hemoglobin A1C Value and Development of Proliferative Diabetic Retinopathy.” Japanese Journal of Ophthalmology, 2001.
Y. Umayahara, Y. Fujita, Hirotaka Watanabe, Noriko Kasai, N. Fujiki, M. Hatazaki, and M. Koga. “Association of Glycated Albumin to HbA1c Ratio with Diabetic Retinopathy but Not Diabetic Nephropathy in Patients with Type 2 Diabetes.” Clinical Biochemistry, 2017.
Yaghoobi Gholamhossein, H. Behrouz, and Z. Asghar. “Diabetic Retinopathy Risk Factors: Plasma Erythropoietin as a Risk Factor for Proliferative Diabetic Retinopathy.” Korean Journal of Ophthalmology, 2014.
Yiyuan Liu, Minghui Wang, A. Morris, A. Doney, G. Leese, E. Pearson, and C. Palmer. “Glycemic Exposure and Blood Pressure Influencing Progression and Remission of Diabetic Retinopathy.” Diabetes Care, 2013.
Yoko Yoshida, Ryoko Hagura, Y. Hara, G. Sugasawa, and Y. Akanuma. “Risk Factors for the Development of Diabetic Retinopathy in Japanese Type 2 Diabetic Patients.” Diabetes Research and Clinical Practice, 2001.
Yu-Ju Wu, Chih-Cheng Hsu, Shang-Jyh Hwang, Kun-Der Lin, Pi-Chen Lin, Ya-Fang Huang, Chien-Hung Lee, Chiao-I Chang, and Meng-Chuan Huang. “Inter-Relations Between Dietary Patterns and Glycemic Control-Related Biomarkers on Risk of Retinopathy in Type 2 Diabetes.” Nutrients, 2024.
Yuni Silalahi, and Ricke Loesnihari. “Relationship of HbA1c to Diabetic Retinopathy in Type 2 DM Patients at Haji Adam Malik General Hospital 2017-2018.” Sumatera Medical Journal, 2021.
Z. Khoso, Moshina Noor Ibrahim, V. Rai, Maira Riaz, T. Laghari, and Israr Ahmed. “Frequency of Diabetic Retinopathy and Its Association with HbA1c in Children and Adolescents with Type-I Diabetes Mellitus.” Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2025.
Zhou Yong-li. “Research on the Relationship Between Glycated Hemoglobin and Diabetic Retinopathy,” 2010.
زينةمحمد حسن, رنا علي حمدي, and ابتهال نوري البصام. “Evaluation of the Role of Serum Malondialdehyde in the Pathogenesis of Diabetic Retinopathy.” Journal of the Faculty of Medicine Baghdad, 2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ayusti Mutazila, Muhamad Ridho (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
